Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma, Large B-Cell, Diffuse | 60 | 2024 | 1405 | 11.490 |
Why?
|
Antigens, CD19 | 22 | 2024 | 424 | 4.700 |
Why?
|
Lymphoma, B-Cell | 19 | 2024 | 938 | 4.630 |
Why?
|
Immunotherapy, Adoptive | 35 | 2024 | 1468 | 4.290 |
Why?
|
Lymphoma, Non-Hodgkin | 23 | 2021 | 1372 | 3.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 62 | 2024 | 11732 | 2.990 |
Why?
|
Hodgkin Disease | 20 | 2024 | 1378 | 2.970 |
Why?
|
Burkitt Lymphoma | 9 | 2023 | 335 | 2.490 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 25 | 2024 | 1640 | 2.100 |
Why?
|
Lymphoma | 16 | 2023 | 1898 | 2.080 |
Why?
|
Doxorubicin | 26 | 2024 | 2224 | 1.980 |
Why?
|
Lymphoma, Follicular | 10 | 2024 | 457 | 1.860 |
Why?
|
Neutropenia | 8 | 2024 | 885 | 1.630 |
Why?
|
Vincristine | 18 | 2024 | 1036 | 1.360 |
Why?
|
Cyclophosphamide | 22 | 2024 | 2219 | 1.300 |
Why?
|
Receptors, Antigen, T-Cell | 7 | 2022 | 2549 | 1.140 |
Why?
|
Central Nervous System Neoplasms | 7 | 2023 | 915 | 1.120 |
Why?
|
Antibodies, Bispecific | 3 | 2024 | 196 | 1.110 |
Why?
|
T-Lymphocytes | 15 | 2024 | 10203 | 1.090 |
Why?
|
Vinblastine | 7 | 2023 | 488 | 1.080 |
Why?
|
Dacarbazine | 8 | 2023 | 559 | 1.060 |
Why?
|
Lymphoma, Mantle-Cell | 5 | 2023 | 237 | 1.020 |
Why?
|
Mediastinal Neoplasms | 3 | 2019 | 401 | 0.990 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 9 | 2015 | 694 | 0.980 |
Why?
|
Prednisone | 17 | 2024 | 1565 | 0.940 |
Why?
|
Hematopoietic Stem Cell Transplantation | 11 | 2023 | 5667 | 0.830 |
Why?
|
Molecular Targeted Therapy | 5 | 2020 | 2813 | 0.820 |
Why?
|
Lymphoma, T-Cell | 4 | 2009 | 303 | 0.800 |
Why?
|
Methotrexate | 5 | 2018 | 1717 | 0.710 |
Why?
|
Translocation, Genetic | 6 | 2022 | 1391 | 0.700 |
Why?
|
Deoxycytidine | 1 | 2024 | 878 | 0.690 |
Why?
|
Antineoplastic Agents | 14 | 2023 | 13630 | 0.680 |
Why?
|
Humans | 198 | 2024 | 761098 | 0.660 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2024 | 709 | 0.620 |
Why?
|
Stem Cell Transplantation | 7 | 2018 | 1600 | 0.580 |
Why?
|
Neoplasm Staging | 24 | 2022 | 11118 | 0.550 |
Why?
|
Neoplasm Recurrence, Local | 13 | 2024 | 9278 | 0.550 |
Why?
|
Disease-Free Survival | 17 | 2022 | 6817 | 0.540 |
Why?
|
Adenine | 6 | 2024 | 986 | 0.540 |
Why?
|
Lymphoma, T-Cell, Peripheral | 2 | 2016 | 125 | 0.540 |
Why?
|
Remission Induction | 8 | 2020 | 2392 | 0.530 |
Why?
|
Etoposide | 9 | 2021 | 634 | 0.530 |
Why?
|
Proto-Oncogene Proteins c-myc | 6 | 2022 | 987 | 0.520 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 3 | 2021 | 48 | 0.510 |
Why?
|
Piperidines | 8 | 2024 | 1656 | 0.500 |
Why?
|
Lymph Nodes | 6 | 2020 | 3461 | 0.500 |
Why?
|
Tuberculosis, Miliary | 1 | 2014 | 13 | 0.470 |
Why?
|
Hepatitis B Surface Antigens | 2 | 2014 | 294 | 0.460 |
Why?
|
Vidarabine | 4 | 2024 | 336 | 0.460 |
Why?
|
Transplantation, Autologous | 8 | 2023 | 2112 | 0.460 |
Why?
|
Herpesvirus 4, Human | 5 | 2023 | 1076 | 0.450 |
Why?
|
Treatment Outcome | 43 | 2024 | 64670 | 0.440 |
Why?
|
Recurrence | 13 | 2023 | 8456 | 0.440 |
Why?
|
Guanine | 1 | 2014 | 278 | 0.440 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 1 | 2014 | 49 | 0.430 |
Why?
|
Lamivudine | 1 | 2014 | 366 | 0.430 |
Why?
|
Aged | 64 | 2024 | 169266 | 0.430 |
Why?
|
Prognosis | 26 | 2024 | 29672 | 0.430 |
Why?
|
Arabinonucleosides | 1 | 2013 | 34 | 0.430 |
Why?
|
Adenine Nucleotides | 1 | 2013 | 110 | 0.420 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 6 | 2022 | 1404 | 0.420 |
Why?
|
Granulocyte Colony-Stimulating Factor | 3 | 2022 | 629 | 0.410 |
Why?
|
Anti-Retroviral Agents | 2 | 2019 | 1784 | 0.390 |
Why?
|
Hepatitis B virus | 2 | 2014 | 527 | 0.390 |
Why?
|
Adult | 67 | 2024 | 221083 | 0.390 |
Why?
|
Patient Selection | 3 | 2020 | 4245 | 0.380 |
Why?
|
Bone Marrow | 5 | 2020 | 2911 | 0.380 |
Why?
|
Splenomegaly | 2 | 2008 | 191 | 0.370 |
Why?
|
Antibodies, Neoplasm | 2 | 2009 | 282 | 0.370 |
Why?
|
Middle Aged | 69 | 2024 | 220835 | 0.360 |
Why?
|
Immunoconjugates | 3 | 2024 | 963 | 0.350 |
Why?
|
Male | 83 | 2024 | 360675 | 0.340 |
Why?
|
Hepatitis B | 2 | 2014 | 704 | 0.340 |
Why?
|
Gene Rearrangement | 5 | 2018 | 1125 | 0.340 |
Why?
|
Leukemia, Prolymphocytic, T-Cell | 1 | 2009 | 23 | 0.340 |
Why?
|
Lymphoma, Large-Cell, Immunoblastic | 1 | 2009 | 25 | 0.340 |
Why?
|
Bleomycin | 5 | 2023 | 494 | 0.340 |
Why?
|
Anthracyclines | 3 | 2023 | 285 | 0.340 |
Why?
|
Female | 83 | 2024 | 392458 | 0.330 |
Why?
|
Neurotoxicity Syndromes | 3 | 2023 | 301 | 0.320 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2013 | 646 | 0.320 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2009 | 164 | 0.310 |
Why?
|
Epstein-Barr Virus Infections | 3 | 2023 | 614 | 0.310 |
Why?
|
Aged, 80 and over | 25 | 2024 | 58946 | 0.310 |
Why?
|
Splenic Neoplasms | 1 | 2008 | 94 | 0.310 |
Why?
|
Benzoquinones | 1 | 2008 | 198 | 0.300 |
Why?
|
Medical Oncology | 5 | 2022 | 2316 | 0.290 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2008 | 178 | 0.280 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2008 | 147 | 0.280 |
Why?
|
Lactams, Macrocyclic | 1 | 2008 | 318 | 0.280 |
Why?
|
Survival Analysis | 10 | 2023 | 10083 | 0.280 |
Why?
|
Treatment Failure | 3 | 2024 | 2643 | 0.270 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3594 | 0.270 |
Why?
|
Immunoglobulin Heavy Chains | 5 | 2019 | 646 | 0.270 |
Why?
|
Lymphoma, AIDS-Related | 2 | 2018 | 79 | 0.270 |
Why?
|
Positron-Emission Tomography | 6 | 2022 | 6585 | 0.260 |
Why?
|
HIV Infections | 8 | 2023 | 17349 | 0.260 |
Why?
|
Sulfonamides | 4 | 2024 | 1977 | 0.260 |
Why?
|
Quinazolinones | 2 | 2019 | 221 | 0.260 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2008 | 422 | 0.260 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2019 | 1895 | 0.250 |
Why?
|
Protein Kinase Inhibitors | 7 | 2024 | 5662 | 0.250 |
Why?
|
Drug Administration Schedule | 5 | 2019 | 4849 | 0.240 |
Why?
|
Combined Modality Therapy | 9 | 2023 | 8519 | 0.240 |
Why?
|
Hydroxamic Acids | 2 | 2018 | 479 | 0.230 |
Why?
|
Purines | 2 | 2019 | 609 | 0.230 |
Why?
|
Thrombocytopenia | 3 | 2022 | 1182 | 0.230 |
Why?
|
Biological Products | 4 | 2021 | 913 | 0.230 |
Why?
|
Karyotyping | 5 | 2015 | 1171 | 0.230 |
Why?
|
Mutation | 11 | 2024 | 30006 | 0.230 |
Why?
|
Diagnosis, Differential | 10 | 2017 | 12975 | 0.220 |
Why?
|
Retrospective Studies | 30 | 2024 | 80673 | 0.220 |
Why?
|
Hypertension | 5 | 2024 | 8537 | 0.220 |
Why?
|
Neutrophils | 4 | 2024 | 3763 | 0.210 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2024 | 367 | 0.210 |
Why?
|
Organoplatinum Compounds | 1 | 2024 | 407 | 0.210 |
Why?
|
Antibodies, Monoclonal | 6 | 2016 | 9185 | 0.210 |
Why?
|
Immunophenotyping | 6 | 2020 | 1867 | 0.210 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2019 | 610 | 0.210 |
Why?
|
Aspergillus fumigatus | 1 | 2024 | 157 | 0.210 |
Why?
|
Spleen | 1 | 2008 | 2290 | 0.200 |
Why?
|
Pyrazoles | 4 | 2024 | 2010 | 0.200 |
Why?
|
Switzerland | 1 | 2023 | 319 | 0.200 |
Why?
|
Chromosome Aberrations | 6 | 2009 | 1767 | 0.200 |
Why?
|
Chylous Ascites | 1 | 2022 | 21 | 0.200 |
Why?
|
Antiviral Agents | 1 | 2014 | 3048 | 0.200 |
Why?
|
Tablets | 1 | 2022 | 148 | 0.200 |
Why?
|
Standard of Care | 2 | 2022 | 550 | 0.200 |
Why?
|
Ribosomal Proteins | 1 | 2024 | 370 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 2 | 2019 | 190 | 0.190 |
Why?
|
DNA Mismatch Repair | 1 | 2024 | 428 | 0.190 |
Why?
|
Immunotherapy | 5 | 2024 | 4642 | 0.180 |
Why?
|
Anemia | 3 | 2020 | 1504 | 0.180 |
Why?
|
Young Adult | 21 | 2024 | 59199 | 0.180 |
Why?
|
Influenza A virus | 2 | 1995 | 458 | 0.180 |
Why?
|
Pyrimidines | 4 | 2024 | 3026 | 0.180 |
Why?
|
Histiocytes | 1 | 2021 | 98 | 0.180 |
Why?
|
Leukapheresis | 1 | 2020 | 134 | 0.180 |
Why?
|
Filgrastim | 1 | 2020 | 132 | 0.180 |
Why?
|
Bone Marrow Cells | 1 | 2008 | 2410 | 0.180 |
Why?
|
Follow-Up Studies | 12 | 2024 | 39121 | 0.170 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2023 | 677 | 0.170 |
Why?
|
Chromosome Deletion | 1 | 2024 | 1386 | 0.170 |
Why?
|
Symporters | 1 | 2022 | 363 | 0.160 |
Why?
|
Bone Marrow Examination | 2 | 2009 | 155 | 0.160 |
Why?
|
Biopsy | 5 | 2023 | 6781 | 0.160 |
Why?
|
Indoles | 2 | 2018 | 1830 | 0.160 |
Why?
|
B-Lymphocytes | 3 | 2022 | 4744 | 0.160 |
Why?
|
Brain Neoplasms | 2 | 2017 | 9025 | 0.150 |
Why?
|
Congresses as Topic | 1 | 2023 | 803 | 0.150 |
Why?
|
Genes, Immunoglobulin | 1 | 2019 | 285 | 0.150 |
Why?
|
Tumor Escape | 1 | 2021 | 371 | 0.150 |
Why?
|
Fatal Outcome | 4 | 2013 | 1837 | 0.150 |
Why?
|
Leukemia, Hairy Cell | 1 | 2017 | 82 | 0.140 |
Why?
|
Disease Management | 3 | 2024 | 2508 | 0.140 |
Why?
|
Leukemia, B-Cell | 1 | 2017 | 84 | 0.140 |
Why?
|
Administration, Oral | 3 | 2019 | 4014 | 0.140 |
Why?
|
Adolescent | 23 | 2024 | 88271 | 0.140 |
Why?
|
Cardiovascular Agents | 1 | 2023 | 842 | 0.140 |
Why?
|
Rare Diseases | 1 | 2022 | 623 | 0.140 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2020 | 4372 | 0.130 |
Why?
|
Herpesvirus 8, Human | 1 | 2018 | 255 | 0.130 |
Why?
|
Antigens, Neoplasm | 2 | 2019 | 1984 | 0.130 |
Why?
|
Legislation, Drug | 1 | 1998 | 214 | 0.130 |
Why?
|
Reactive Oxygen Species | 1 | 2024 | 2138 | 0.130 |
Why?
|
Morpholines | 1 | 2019 | 581 | 0.130 |
Why?
|
Drug Labeling | 1 | 1998 | 248 | 0.130 |
Why?
|
Risk | 3 | 2019 | 9614 | 0.130 |
Why?
|
Safety | 1 | 2020 | 1151 | 0.130 |
Why?
|
Abortion, Spontaneous | 1 | 2001 | 532 | 0.130 |
Why?
|
Holography | 1 | 2016 | 80 | 0.130 |
Why?
|
Infusions, Intravenous | 1 | 2020 | 2217 | 0.130 |
Why?
|
Genes, bcl-2 | 1 | 2015 | 119 | 0.130 |
Why?
|
Sarcoma, Kaposi | 1 | 2018 | 374 | 0.120 |
Why?
|
Bone Marrow Neoplasms | 1 | 2015 | 101 | 0.120 |
Why?
|
Interferon Regulatory Factors | 1 | 2016 | 261 | 0.120 |
Why?
|
Ifosfamide | 2 | 2015 | 232 | 0.120 |
Why?
|
Transplantation Chimera | 1 | 2017 | 594 | 0.120 |
Why?
|
Polyethylene Glycols | 1 | 2020 | 1187 | 0.120 |
Why?
|
Hematologic Diseases | 3 | 2019 | 496 | 0.120 |
Why?
|
Genes, myc | 1 | 2015 | 390 | 0.120 |
Why?
|
Biphenyl Compounds | 1 | 2019 | 1007 | 0.120 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3869 | 0.110 |
Why?
|
Clinical Trials as Topic | 7 | 2021 | 8000 | 0.110 |
Why?
|
Neoplasms | 7 | 2022 | 22125 | 0.110 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2016 | 242 | 0.110 |
Why?
|
Sialoglycoproteins | 1 | 1995 | 315 | 0.110 |
Why?
|
Atrial Fibrillation | 2 | 2024 | 5115 | 0.110 |
Why?
|
Thyroid Gland | 1 | 2001 | 1170 | 0.110 |
Why?
|
Bismuth | 1 | 1993 | 29 | 0.110 |
Why?
|
Nervous System Diseases | 2 | 2024 | 1663 | 0.110 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1995 | 890 | 0.110 |
Why?
|
Pyridones | 1 | 2019 | 809 | 0.110 |
Why?
|
NF-kappa B | 1 | 2022 | 2475 | 0.110 |
Why?
|
Liver | 2 | 2016 | 7513 | 0.110 |
Why?
|
Drug Delivery Systems | 1 | 2005 | 2223 | 0.110 |
Why?
|
Gene Expression Profiling | 4 | 2019 | 9416 | 0.110 |
Why?
|
Diarrhea, Infantile | 1 | 1993 | 100 | 0.110 |
Why?
|
Benzamides | 1 | 2019 | 1370 | 0.110 |
Why?
|
Salicylates | 1 | 1993 | 127 | 0.110 |
Why?
|
Cytarabine | 2 | 2015 | 697 | 0.110 |
Why?
|
Leukemia, Myeloid | 2 | 2006 | 693 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 6 | 2017 | 20600 | 0.110 |
Why?
|
Germinal Center | 1 | 2015 | 380 | 0.100 |
Why?
|
Kidney Transplantation | 1 | 2008 | 4240 | 0.100 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2024 | 4340 | 0.100 |
Why?
|
Proportional Hazards Models | 3 | 2023 | 12467 | 0.100 |
Why?
|
Heart Failure | 5 | 2023 | 11701 | 0.100 |
Why?
|
Carmustine | 1 | 2012 | 137 | 0.100 |
Why?
|
Autoantibodies | 1 | 2001 | 2117 | 0.100 |
Why?
|
Staining and Labeling | 1 | 2016 | 1081 | 0.100 |
Why?
|
Lymphatic Diseases | 2 | 2013 | 320 | 0.100 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2020 | 5300 | 0.090 |
Why?
|
Fever | 3 | 2009 | 1618 | 0.090 |
Why?
|
Orthomyxoviridae Infections | 1 | 1994 | 254 | 0.090 |
Why?
|
Transplantation, Homologous | 3 | 2020 | 4822 | 0.090 |
Why?
|
Cancer Care Facilities | 1 | 2014 | 422 | 0.090 |
Why?
|
Deltaretrovirus Antibodies | 2 | 2009 | 9 | 0.090 |
Why?
|
Tumor Burden | 2 | 2017 | 1892 | 0.090 |
Why?
|
Botswana | 3 | 2021 | 1049 | 0.090 |
Why?
|
Biopsy, Fine-Needle | 3 | 2022 | 1118 | 0.090 |
Why?
|
Mouth Neoplasms | 1 | 2016 | 596 | 0.090 |
Why?
|
Alternaria | 1 | 2011 | 42 | 0.090 |
Why?
|
Dermatomycoses | 1 | 2011 | 48 | 0.090 |
Why?
|
Antigens, CD | 2 | 2006 | 4008 | 0.090 |
Why?
|
Thorax | 1 | 2014 | 555 | 0.090 |
Why?
|
Survival Rate | 7 | 2021 | 12727 | 0.090 |
Why?
|
Recombinant Proteins | 1 | 2020 | 6507 | 0.090 |
Why?
|
Immunologic Factors | 2 | 2016 | 1589 | 0.090 |
Why?
|
Heart Diseases | 1 | 2023 | 2795 | 0.090 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2010 | 57 | 0.090 |
Why?
|
Organometallic Compounds | 1 | 1993 | 647 | 0.090 |
Why?
|
Disease Progression | 3 | 2019 | 13506 | 0.090 |
Why?
|
Quality of Life | 2 | 2022 | 13362 | 0.090 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2010 | 91 | 0.090 |
Why?
|
Databases, Genetic | 1 | 2017 | 1741 | 0.080 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 1 | 2009 | 111 | 0.080 |
Why?
|
Pneumococcal Infections | 1 | 1994 | 501 | 0.080 |
Why?
|
Cardiovascular Diseases | 3 | 2022 | 15513 | 0.080 |
Why?
|
Polymerase Chain Reaction | 2 | 2016 | 6067 | 0.080 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2013 | 617 | 0.080 |
Why?
|
Sirolimus | 2 | 2015 | 1540 | 0.080 |
Why?
|
Brain Diseases | 1 | 2018 | 1546 | 0.080 |
Why?
|
Paraproteins | 1 | 2008 | 38 | 0.080 |
Why?
|
Transplantation Conditioning | 3 | 2012 | 1591 | 0.080 |
Why?
|
Drug Discovery | 1 | 2016 | 1049 | 0.080 |
Why?
|
Humanities | 1 | 2009 | 55 | 0.080 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2008 | 71 | 0.080 |
Why?
|
Epidemics | 1 | 2014 | 512 | 0.080 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12058 | 0.080 |
Why?
|
Injections, Intravenous | 1 | 2010 | 1376 | 0.080 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2016 | 2787 | 0.070 |
Why?
|
Hematologic Tests | 1 | 2008 | 239 | 0.070 |
Why?
|
Incidence | 4 | 2020 | 21357 | 0.070 |
Why?
|
Ventricular Function, Left | 2 | 2023 | 3899 | 0.070 |
Why?
|
Reed-Sternberg Cells | 1 | 2007 | 72 | 0.070 |
Why?
|
Radiography, Thoracic | 1 | 2014 | 1303 | 0.070 |
Why?
|
C-Reactive Protein | 3 | 2023 | 3821 | 0.070 |
Why?
|
Testicular Neoplasms | 1 | 2013 | 800 | 0.070 |
Why?
|
Splenectomy | 1 | 2008 | 391 | 0.070 |
Why?
|
Pancytopenia | 1 | 2008 | 102 | 0.070 |
Why?
|
Meningitis | 2 | 1986 | 217 | 0.070 |
Why?
|
Neoplasm, Residual | 2 | 2022 | 1008 | 0.070 |
Why?
|
CD4 Lymphocyte Count | 1 | 2013 | 2569 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 4574 | 0.070 |
Why?
|
Societies, Medical | 1 | 2019 | 3923 | 0.070 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2023 | 2025 | 0.070 |
Why?
|
Galectin 1 | 1 | 2007 | 128 | 0.070 |
Why?
|
Pulmonary Fibrosis | 1 | 2010 | 505 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 6482 | 0.070 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2008 | 346 | 0.060 |
Why?
|
Fatigue | 2 | 2012 | 1550 | 0.060 |
Why?
|
Central Nervous System | 2 | 2023 | 1333 | 0.060 |
Why?
|
Transcription Factor AP-1 | 1 | 2007 | 319 | 0.060 |
Why?
|
Genome, Human | 1 | 2019 | 4423 | 0.060 |
Why?
|
Hand | 1 | 2011 | 902 | 0.060 |
Why?
|
Blood Coagulation Disorders | 1 | 2008 | 350 | 0.060 |
Why?
|
United States | 9 | 2020 | 72337 | 0.060 |
Why?
|
Depression | 2 | 2001 | 8130 | 0.060 |
Why?
|
Exanthema | 1 | 2009 | 503 | 0.060 |
Why?
|
Multiple Myeloma | 1 | 2022 | 5145 | 0.060 |
Why?
|
Registries | 2 | 2019 | 8236 | 0.060 |
Why?
|
Secondary Prevention | 1 | 2011 | 1472 | 0.060 |
Why?
|
Hematuria | 2 | 2017 | 232 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2008 | 1696 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2024 | 9566 | 0.060 |
Why?
|
Immunoglobulin M | 1 | 2008 | 1527 | 0.060 |
Why?
|
Diarrhea | 2 | 2023 | 1318 | 0.050 |
Why?
|
Radiotherapy | 1 | 2010 | 1498 | 0.050 |
Why?
|
Double-Blind Method | 3 | 2024 | 12341 | 0.050 |
Why?
|
Acyclovir | 1 | 1984 | 267 | 0.050 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2014 | 2197 | 0.050 |
Why?
|
Emigrants and Immigrants | 1 | 2009 | 544 | 0.050 |
Why?
|
Orthomyxoviridae | 1 | 1984 | 149 | 0.050 |
Why?
|
Age Factors | 3 | 2016 | 18385 | 0.050 |
Why?
|
Lymphoproliferative Disorders | 1 | 2006 | 530 | 0.050 |
Why?
|
Radiation Injuries | 1 | 2010 | 1191 | 0.050 |
Why?
|
Heart Ventricles | 1 | 2015 | 3812 | 0.050 |
Why?
|
Enzyme Activation | 1 | 2008 | 3577 | 0.050 |
Why?
|
Electroencephalography | 1 | 2018 | 6242 | 0.050 |
Why?
|
Busulfan | 2 | 2015 | 258 | 0.050 |
Why?
|
Myeloproliferative Disorders | 1 | 2008 | 609 | 0.050 |
Why?
|
Mediastinum | 2 | 2015 | 267 | 0.050 |
Why?
|
Echocardiography | 1 | 2015 | 5006 | 0.050 |
Why?
|
Risk Assessment | 4 | 2018 | 24013 | 0.050 |
Why?
|
Aspergillosis | 1 | 2024 | 242 | 0.050 |
Why?
|
Dexamethasone | 2 | 2022 | 1945 | 0.050 |
Why?
|
Developing Countries | 1 | 2014 | 2862 | 0.050 |
Why?
|
Stroke Volume | 3 | 2023 | 5520 | 0.050 |
Why?
|
Pulse | 1 | 2001 | 218 | 0.050 |
Why?
|
Abdominal Pain | 1 | 2008 | 1071 | 0.050 |
Why?
|
Consensus | 2 | 2024 | 3133 | 0.050 |
Why?
|
Chemotaxis | 1 | 1984 | 598 | 0.050 |
Why?
|
Genes, Neoplasm | 1 | 2023 | 370 | 0.050 |
Why?
|
Gene Deletion | 1 | 2008 | 2656 | 0.050 |
Why?
|
DNA, Viral | 2 | 2018 | 2195 | 0.050 |
Why?
|
Central Nervous System Diseases | 1 | 1985 | 521 | 0.040 |
Why?
|
Herpes Simplex | 1 | 1984 | 465 | 0.040 |
Why?
|
Radiopharmaceuticals | 2 | 2023 | 2682 | 0.040 |
Why?
|
Abortion, Habitual | 1 | 2001 | 61 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3776 | 0.040 |
Why?
|
Lymphocyte Activation | 2 | 2024 | 5478 | 0.040 |
Why?
|
Encephalitis | 1 | 1984 | 439 | 0.040 |
Why?
|
Pneumonia | 1 | 2012 | 2142 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2008 | 2455 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 1998 | 7405 | 0.040 |
Why?
|
Practice Guidelines as Topic | 2 | 2016 | 7400 | 0.040 |
Why?
|
RNA, Small Interfering | 1 | 2008 | 3409 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2018 | 10755 | 0.040 |
Why?
|
Organizations, Nonprofit | 1 | 2020 | 105 | 0.040 |
Why?
|
Safety-Based Drug Withdrawals | 1 | 2019 | 36 | 0.040 |
Why?
|
Systole | 1 | 2001 | 936 | 0.040 |
Why?
|
Maximum Tolerated Dose | 1 | 2021 | 883 | 0.040 |
Why?
|
Glycoproteins | 1 | 2006 | 2203 | 0.040 |
Why?
|
Prospective Studies | 6 | 2022 | 54419 | 0.040 |
Why?
|
Brain | 2 | 2017 | 27097 | 0.040 |
Why?
|
Child | 12 | 2023 | 80134 | 0.040 |
Why?
|
Viral Load | 2 | 2018 | 3328 | 0.040 |
Why?
|
Ethics | 1 | 1998 | 94 | 0.040 |
Why?
|
Fanconi Anemia | 1 | 2001 | 324 | 0.040 |
Why?
|
Phagocytosis | 1 | 2024 | 1525 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12145 | 0.040 |
Why?
|
Glioblastoma | 1 | 2013 | 3481 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13382 | 0.040 |
Why?
|
Deltaretrovirus Infections | 2 | 1988 | 25 | 0.040 |
Why?
|
South Africa | 1 | 2023 | 1843 | 0.040 |
Why?
|
Workflow | 1 | 2022 | 850 | 0.040 |
Why?
|
Education, Medical | 1 | 2009 | 1725 | 0.040 |
Why?
|
Ferritins | 1 | 2020 | 597 | 0.040 |
Why?
|
Myocardium | 1 | 2010 | 4746 | 0.040 |
Why?
|
Cytidine Deaminase | 1 | 2019 | 242 | 0.030 |
Why?
|
Sodium | 1 | 2022 | 1589 | 0.030 |
Why?
|
Risk Factors | 6 | 2021 | 74219 | 0.030 |
Why?
|
Chromosomes, Human, Pair 7 | 2 | 1988 | 310 | 0.030 |
Why?
|
Retroperitoneal Space | 1 | 2017 | 170 | 0.030 |
Why?
|
Child, Preschool | 9 | 2019 | 42217 | 0.030 |
Why?
|
Troponin | 1 | 2019 | 504 | 0.030 |
Why?
|
Cisplatin | 1 | 2022 | 1651 | 0.030 |
Why?
|
Students, Medical | 1 | 2009 | 1938 | 0.030 |
Why?
|
Cohort Studies | 4 | 2021 | 41486 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2018 | 781 | 0.030 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2017 | 232 | 0.030 |
Why?
|
Infant | 8 | 2019 | 36164 | 0.030 |
Why?
|
Retreatment | 1 | 2017 | 598 | 0.030 |
Why?
|
Chromosome Disorders | 3 | 1987 | 497 | 0.030 |
Why?
|
Forefoot, Human | 1 | 2014 | 31 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2017 | 590 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2014 | 36418 | 0.030 |
Why?
|
Drug Therapy | 1 | 2017 | 503 | 0.030 |
Why?
|
Radioimmunotherapy | 1 | 2014 | 91 | 0.030 |
Why?
|
Chinchilla | 1 | 1994 | 75 | 0.030 |
Why?
|
Hepatitis, Autoimmune | 1 | 2016 | 172 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2010 | 8529 | 0.030 |
Why?
|
Cytodiagnosis | 1 | 2017 | 447 | 0.030 |
Why?
|
Clinical Competence | 1 | 2009 | 4786 | 0.030 |
Why?
|
Jaw | 1 | 2013 | 93 | 0.030 |
Why?
|
Forkhead Transcription Factors | 2 | 2013 | 1612 | 0.030 |
Why?
|
Interinstitutional Relations | 1 | 2014 | 236 | 0.030 |
Why?
|
Nausea | 1 | 2016 | 679 | 0.030 |
Why?
|
Microspheres | 1 | 2016 | 783 | 0.030 |
Why?
|
Aftercare | 1 | 2019 | 913 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2008 | 10421 | 0.030 |
Why?
|
Cytomegalovirus | 1 | 2017 | 749 | 0.030 |
Why?
|
Hematologic Neoplasms | 1 | 2024 | 1895 | 0.030 |
Why?
|
Apoptosis | 1 | 2008 | 9478 | 0.030 |
Why?
|
Hepatitis B Antibodies | 1 | 2013 | 155 | 0.030 |
Why?
|
Infant, Newborn | 5 | 2019 | 26187 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2022 | 1935 | 0.030 |
Why?
|
Data Collection | 1 | 2021 | 3319 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2008 | 16947 | 0.020 |
Why?
|
Lymphocytes | 1 | 2020 | 2603 | 0.020 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 1988 | 3609 | 0.020 |
Why?
|
Thiotepa | 1 | 2011 | 66 | 0.020 |
Why?
|
Lung | 1 | 2010 | 9979 | 0.020 |
Why?
|
Capacity Building | 1 | 2014 | 259 | 0.020 |
Why?
|
Tacrolimus | 1 | 2015 | 735 | 0.020 |
Why?
|
Confusion | 1 | 2013 | 278 | 0.020 |
Why?
|
Mycological Typing Techniques | 1 | 2011 | 10 | 0.020 |
Why?
|
DNA, Ribosomal Spacer | 1 | 2011 | 28 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2015 | 1900 | 0.020 |
Why?
|
Comorbidity | 2 | 2017 | 10514 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2016 | 773 | 0.020 |
Why?
|
Virus Activation | 1 | 2013 | 319 | 0.020 |
Why?
|
Radiation, Ionizing | 1 | 2012 | 252 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2024 | 5494 | 0.020 |
Why?
|
Hypercalcemia | 1 | 2013 | 423 | 0.020 |
Why?
|
Cytomegalovirus Infections | 1 | 2017 | 828 | 0.020 |
Why?
|
Radiography, Abdominal | 1 | 2013 | 534 | 0.020 |
Why?
|
Subcutaneous Tissue | 1 | 2011 | 132 | 0.020 |
Why?
|
Glucose | 1 | 2022 | 4341 | 0.020 |
Why?
|
Survivors | 1 | 2020 | 2369 | 0.020 |
Why?
|
Drug Therapy, Combination | 2 | 2018 | 6305 | 0.020 |
Why?
|
Advisory Committees | 1 | 2014 | 788 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 1998 | 1661 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2020 | 2632 | 0.020 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 1549 | 0.020 |
Why?
|
Fluid Therapy | 1 | 1993 | 578 | 0.020 |
Why?
|
DNA, Fungal | 1 | 2011 | 275 | 0.020 |
Why?
|
Education, Premedical | 1 | 2009 | 17 | 0.020 |
Why?
|
Molecular Imaging | 1 | 2016 | 819 | 0.020 |
Why?
|
Time Factors | 4 | 2017 | 39953 | 0.020 |
Why?
|
Virus Replication | 1 | 2017 | 2426 | 0.020 |
Why?
|
Europe | 1 | 2016 | 3422 | 0.020 |
Why?
|
Bronchiectasis | 1 | 2010 | 139 | 0.020 |
Why?
|
Aspartate Aminotransferases | 1 | 2010 | 411 | 0.020 |
Why?
|
RNA, Viral | 1 | 2017 | 2839 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2914 | 0.020 |
Why?
|
Signal Transduction | 2 | 2024 | 23415 | 0.020 |
Why?
|
Streptococcus pyogenes | 1 | 1991 | 292 | 0.020 |
Why?
|
Debridement | 1 | 2011 | 493 | 0.020 |
Why?
|
Shock | 1 | 2010 | 314 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2015 | 11066 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2001 | 4189 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2017 | 2054 | 0.020 |
Why?
|
Alanine Transaminase | 1 | 2010 | 602 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15308 | 0.020 |
Why?
|
Thalidomide | 1 | 2013 | 885 | 0.020 |
Why?
|
Urinary Bladder | 1 | 2013 | 1152 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8639 | 0.020 |
Why?
|
Coronary Disease | 1 | 2001 | 5921 | 0.020 |
Why?
|
Graft vs Host Disease | 2 | 2015 | 3026 | 0.020 |
Why?
|
Cefuroxime | 1 | 1986 | 23 | 0.020 |
Why?
|
Chloramphenicol | 1 | 1986 | 67 | 0.020 |
Why?
|
Brachytherapy | 1 | 2014 | 1223 | 0.020 |
Why?
|
Streptococcal Infections | 1 | 1991 | 617 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2019 | 2293 | 0.020 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 1988 | 386 | 0.020 |
Why?
|
Ampicillin | 1 | 1986 | 136 | 0.020 |
Why?
|
Chromosomes, Human, 21-22 and Y | 1 | 1985 | 45 | 0.020 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 1987 | 286 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2012 | 1386 | 0.020 |
Why?
|
Chromosomes, Human, 4-5 | 1 | 1985 | 26 | 0.020 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 1987 | 277 | 0.020 |
Why?
|
Chromosomes, Human, 6-12 and X | 1 | 1985 | 69 | 0.020 |
Why?
|
Antifungal Agents | 1 | 2011 | 753 | 0.020 |
Why?
|
Anxiety | 1 | 2020 | 4572 | 0.020 |
Why?
|
Latex Fixation Tests | 1 | 1985 | 29 | 0.020 |
Why?
|
Trisomy | 1 | 1987 | 260 | 0.020 |
Why?
|
Coagulase | 1 | 1985 | 53 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 2011 | 858 | 0.020 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 1987 | 430 | 0.020 |
Why?
|
Cytogenetics | 1 | 1985 | 198 | 0.020 |
Why?
|
Cephalosporins | 1 | 1986 | 198 | 0.020 |
Why?
|
Staphylococcus | 1 | 1985 | 153 | 0.010 |
Why?
|
Empathy | 1 | 2009 | 473 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5333 | 0.010 |
Why?
|
Coronary Stenosis | 1 | 2010 | 802 | 0.010 |
Why?
|
Shock, Septic | 1 | 1991 | 769 | 0.010 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 1 | 1984 | 221 | 0.010 |
Why?
|
Carboxymethylcellulose Sodium | 1 | 1984 | 38 | 0.010 |
Why?
|
Contrast Media | 1 | 2017 | 5311 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2010 | 2508 | 0.010 |
Why?
|
Poly I-C | 1 | 1984 | 112 | 0.010 |
Why?
|
Lactoferrin | 1 | 1984 | 100 | 0.010 |
Why?
|
Polylysine | 1 | 1984 | 131 | 0.010 |
Why?
|
World Health Organization | 1 | 2010 | 1321 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 3367 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2010 | 1264 | 0.010 |
Why?
|
Pediatrics | 1 | 1998 | 3589 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4308 | 0.010 |
Why?
|
Hepatitis C | 1 | 2013 | 1579 | 0.010 |
Why?
|
False Positive Reactions | 1 | 1985 | 958 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2010 | 1528 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2013 | 2974 | 0.010 |
Why?
|
Dyspnea | 1 | 2010 | 1347 | 0.010 |
Why?
|
Massachusetts | 1 | 2015 | 8836 | 0.010 |
Why?
|
Cerebrospinal Fluid | 1 | 1985 | 544 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2014 | 2020 | 0.010 |
Why?
|
Th2 Cells | 1 | 2007 | 1071 | 0.010 |
Why?
|
Immunity, Innate | 1 | 1994 | 3044 | 0.010 |
Why?
|
Interferon Type I | 1 | 1985 | 557 | 0.010 |
Why?
|
Radiography | 2 | 2010 | 6975 | 0.010 |
Why?
|
Boston | 1 | 2014 | 9324 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2013 | 4510 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16572 | 0.010 |
Why?
|
Animals | 3 | 2015 | 168083 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 7969 | 0.010 |
Why?
|
HIV-1 | 1 | 2017 | 6851 | 0.010 |
Why?
|
Nuclear Family | 1 | 2001 | 311 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2011 | 4739 | 0.010 |
Why?
|
Stroke | 1 | 2001 | 9720 | 0.010 |
Why?
|
Histocompatibility Testing | 1 | 2001 | 716 | 0.010 |
Why?
|
Pregnancy | 1 | 2001 | 29872 | 0.010 |
Why?
|
Pain | 1 | 2013 | 5070 | 0.010 |
Why?
|
Immune Tolerance | 1 | 2007 | 2307 | 0.010 |
Why?
|
Bacterial Infections | 1 | 1986 | 1390 | 0.010 |
Why?
|
Cell Adhesion | 1 | 1984 | 3090 | 0.010 |
Why?
|
Hip Joint | 1 | 1984 | 1014 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2009 | 2372 | 0.010 |
Why?
|
Acute Disease | 1 | 2006 | 7240 | 0.010 |
Why?
|
Curriculum | 1 | 2009 | 3739 | 0.010 |
Why?
|
Cell Membrane | 1 | 1984 | 3665 | 0.010 |
Why?
|
Algorithms | 1 | 2015 | 14023 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2007 | 3092 | 0.010 |
Why?
|
Evaluation Studies as Topic | 2 | 1985 | 1624 | 0.010 |
Why?
|
Cytokines | 1 | 2007 | 7386 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2013 | 11103 | 0.010 |
Why?
|
Serotyping | 1 | 1991 | 325 | 0.010 |
Why?
|
North Carolina | 1 | 1991 | 324 | 0.010 |
Why?
|
Cause of Death | 1 | 2001 | 3688 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2010 | 11475 | 0.010 |
Why?
|
Pharyngitis | 1 | 1991 | 220 | 0.010 |
Why?
|
Internship and Residency | 1 | 2009 | 5879 | 0.010 |
Why?
|
Deltaretrovirus | 1 | 1988 | 162 | 0.000 |
Why?
|
Chromosome Banding | 1 | 1987 | 260 | 0.000 |
Why?
|
Meningitis, Haemophilus | 1 | 1986 | 20 | 0.000 |
Why?
|
Meningitis, Meningococcal | 1 | 1986 | 43 | 0.000 |
Why?
|
Meningitis, Pneumococcal | 1 | 1986 | 43 | 0.000 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2001 | 10213 | 0.000 |
Why?
|
Random Allocation | 1 | 1986 | 2393 | 0.000 |
Why?
|
Hip Dislocation | 1 | 1984 | 248 | 0.000 |
Why?
|
Pedigree | 1 | 1988 | 4537 | 0.000 |
Why?
|
Biopsy, Needle | 1 | 1984 | 1624 | 0.000 |
Why?
|
Physical Examination | 1 | 1984 | 1255 | 0.000 |
Why?
|
Sepsis | 1 | 1991 | 2586 | 0.000 |
Why?
|
Antibodies, Viral | 1 | 1988 | 3149 | 0.000 |
Why?
|